Pharmafile Logo
Pharmafocus logo
Advanced Search

Mannkind

Showing 10 posts of 10 posts found.

david_kendall

MannKind entices Lilly VP to CMO role

February 9, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, Mannkind, biotech, drugs, pharma, pharmaceutical

MannKind, the California-based biotech, announced that David Kendall would be joining its team as Chief Medical Officer and would be …

Appointment
matthewpfeffer_sm

New chief exec at MannKind

January 25, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Alfred Mann, Duane DeSisto, Insulet, Mannkind, Matthew Pffefer

The board of directors of MannKind have appointed Matthew Pfeffer as chief executive of MannKind.He replaces Alfred Mann who has …

Appointment
afrezza_insulin

Sanofi abandons MannKind’s failed inhalable insulin

January 6, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Afrezza, Mannkind, Sanofi, insulin

Sanofi is to exit a licensing and co-marketing deal with MannKind for the inhalable insulin Afrezza, after disappointing sales figures …

News
affrezza image

Sanofi’s inhalable insulin goes on sale in US

February 3, 2015
Sales and Marketing Afrezza, FDA, Mannkind, Sanofi, US, apidra, diabetes, insulin, type 1, type 2

Sanofi has launched its inhalable insulin Afrezza in the US to control blood sugar in people with type 1 and …

News
Affreza image

FDA ‘yes’ to inhaled insulin

June 30, 2014
Manufacturing and Production, Sales and Marketing Afrezza, FDA, Mannkind, diabetes, insulin human

The FDA has approved the first ‘ultra-rapid-acting’ mealtime insulin therapy available in the US, to improve glycemic control in both …

News
Afrezza image

Inhaled insulin one step closer to approval

April 3, 2014
Sales and Marketing Afrezza, FDA, Mannkind, diabetes, type 1, type 2

After a rocky few years MannKind’s inhaled insulin Afrezza finally looks to be on the path to approval in the …

News
manufacturing_compounding

Mannkind’s inhaled insulin Afrezza edges closer to market

August 19, 2013
Research and Development, Sales and Marketing Afrezza, Exubera, Mannkind, inhaled insulin

News

Awards recognise top pharma manufacturing projects

January 19, 2010
Manufacturing and Production Biogen, Genentech, Mannkind, Pfizer

The winners of the 2010 Facility of the Year Awards have been made public, with Pfizer grabbing two out of …

News

Manufacturing news in brief

January 12, 2010
Manufacturing and Production ACell, Cel-Sci, Dr Reddy's Laboratories, Genzyme, Mannkind, Pfizer, Transgene Biotek, Viva Pharmaceutical

This week’s rundown of manufacturing news includes a delay for Mannkind’s inhaled insulin product Afrezza, more job losses at Pfizer …

News

Mannkind picks up Pfizer’s Exubera facility

March 16, 2009
Manufacturing and Production Mannkind, diabetes

The demise of Pfizer's inhaled diabetes treatment Exubera cast a pall over the prospects for inhaled insulin therapy, but has …

News

Latest content

Novo Nordisk partners with UNICEF to prevent global childhood obesity

September 21, 2023

EC approves Menarini Group’s Orserdu for breast cancer treatment

September 21, 2023

Pharmanovia acquires CNS portfolio from Sanofi

September 20, 2023

Exscientia enters AI drug discovery collaboration with Merck KGaA

September 20, 2023

EC approves Pfizer’s Litfulo for adolescents and adults with alopecia

September 19, 2023